近期结肠镜检查后粪便免疫化学检测阳性无症状个体的重复结肠镜检查检出率
该研究比较了近期结肠镜检查后粪便免疫化学检测(FIT)阳性无症状筛查者中结直肠癌(CRC)和进展期结直肠肿瘤(ACRN)的患病率。在2228例FIT阳性参与者中,距上次结肠镜检查不足3年者(组1)的CRC和ACRN检出率分别为2.1%和10.9%,均低于10年以上或无结肠镜检查者(组3)的7.2%和26.0%,但不低于3至10年者(组2)。研究支持美国多学会工作组关于对FIT阳性且近期结肠镜检查者重复结肠镜检查的推荐。
要点
- FIT阳性且3年内曾行结肠镜检查者,CRC和ACRN患病率分别为2.1%和10.9%,并不低。
- FIT阳性者中,距上次结肠镜不足3年组的CRC和ACRN检出率低于10年以上或无结肠镜组。
- 所有3个组中,FIT阳性者的CRC和ACRN检出率均显著高于FIT阴性者。
核心结论
- 在FIT阳性且既往3年内行结肠镜检查的患者中,CRC和ACRN患病率并不低。
- 研究结果支持美国多学会工作组关于结直肠癌筛查的推荐,即对FIT阳性且近期行结肠镜检查的患者提供重复结肠镜检查。
研究设计与样本
- 研究回顾了年龄≥50岁、接受FIT和结肠镜检查的无症状筛查者。
- 共纳入2228例FIT阳性参与者,按距上次结肠镜检查时间分组:组1为不足3年(514例),组2为3至10年(427例),组3为超过10年或无结肠镜检查(1287例)。
- 另纳入6135例FIT阴性参与者进行对比。
主要发现
- FIT阳性者中,组1、组2、组3的CRC患病率分别为2.1%、1.6%、7.2%,ACRN患病率分别为10.9%、12.6%、26.0%。
- 调整混杂因素后,组1的CRC和ACRN检出率低于组3,但不低于组2。
- FIT阴性者中,组1、组2、组3的CRC患病率分别为0.7%、0.4%、3.4%,ACRN患病率分别为6.0%、6.1%、14.7%。
- 在所有3个组中,FIT阳性者的CRC和ACRN检出率均显著高于FIT阴性者。
临床怎么用
- 作者结论支持美国多学会工作组的推荐:对FIT阳性且近期行结肠镜检查的患者提供重复结肠镜检查。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: A fecal immunochemical test (FIT) is often repeated annually, even after a recent colonoscopy. However, there are no published data on the proper approach to FIT-positive patients after a recent colonoscopy. We compared colorectal cancer (CRC) and advanced colorectal neoplasia (ACRN) prevalence based on the interval since the last colonoscopy. METHODS: We reviewed asymptomatic screenees aged ≥50 years who underwent FIT and colonoscopy. RESULTS: Of 2228 FIT-positive participants, 514 had a colonoscopy less than 3 years before (group 1), 427 had a colonoscopy had a colonoscopy 3 to 10 years before (group 2), and 1287 had a colonoscopy >10 years before or no colonoscopy (group 3). The prevalence of CRC in groups 1, 2, and 3 was 2.1%, 1.6%, and 7.2%, respectively, and that for ACRN was 10.9%, 12.6%, and 26.0%, respectively. Even after adjusting for confounders, CRC and ACRN detection rates in group 1 were lower than those in group 3 but not lower than those in group 2. Among 6135 FIT-negative participants, the prevalence of CRC in the 3 groups was .7%, .4%, and 3.4%, respectively, and that for ACRN was 6.0%, 6.1%, and 14.7%, respectively. CRC and ACRN detection rates were significantly higher in FIT-positive participants than in FIT-negative participants in all 3 groups. CONCLUSIONS: In FIT-positive patients who underwent colonoscopy within the prior 3 years, CRC and ACRN prevalence was not low. Our findings support the U.S. Multi-Society Task Force on the CRC screening recommendation that repeat colonoscopy be offered to patients with positive FIT results and recent colonoscopy.
引用
- Kim NH, Jung YS, Lim JW, et al. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy. Gastrointest Endosc. 2019. PMID: 30684602. doi:10.1016/j.gie.2019.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。